Thrivent Financial for Lutherans
VIR icon

Thrivent Financial for Lutherans’s Vir Biotechnology VIR Stock Holding History

Thrivent Financial for Lutherans’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.35M Buy
132,338
+18,745
+17% +$178K ﹤0.01% 1813
2026
Q1 		$1.02M Buy
113,593
+48,587
+75% +$387K ﹤0.01% 1869
2025
Q4 		$392K Sell
65,006
-3,143
-5% -$18.7K ﹤0.01% 2337
2025
Q3 		$389K Buy
68,149
+44
+0.1% +$225 ﹤0.01% 2169
2025
Q2 		$343K Buy
68,105
+329
+0.5% +$1.76K ﹤0.01% 2267
2025
Q1 		$439K Sell
67,776
-3,546
-5% -$31.5K ﹤0.01% 2123
2024
Q4 		$524K Sell
71,322
-570
-0.8% -$4.5K ﹤0.01% 2237
2024
Q3 		$538K Sell
71,892
-395
-0.5% -$3.43K ﹤0.01% 2225
2024
Q2 		$643K Sell
72,287
-2,401
-3% -$23K ﹤0.01% 2115
2024
Q1 		$757K Sell
74,688
-2,028
-3% -$20.7K ﹤0.01% 2046
2023
Q4 		$772K Sell
76,716
-1,884
-2% -$17.2K ﹤0.01% 2002
2023
Q3 		$736K Buy
78,600
+5,545
+8% +$79.1K ﹤0.01% 1927
2023
Q2 		$1.79M Sell
73,055
-2,139
-3% -$53.7K ﹤0.01% 1412
2023
Q1 		$1.75M Sell
75,194
-2,636
-3% -$67.4K ﹤0.01% 1392
2022
Q4 		$1.97M Sell
77,830
-323
-0.4% -$7.92K 0.01% 1273
2022
Q3 		$1.51M Buy
78,153
+5,323
+7% +$135K ﹤0.01% 1403
2022
Q2 		$1.85M Buy
+72,830
New +$1.7M ﹤0.01% 1266

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Thrivent Financial for Lutherans's VIR Position: Q2 2026 in Review

Thrivent Financial for Lutherans increased its Vir Biotechnology (VIR) stake by 17% in Q2 2026, buying an estimated $178K and bringing the position to 132,338 shares worth $1.35M. The position accounts for ﹤0.01% of the portfolio, ranked #1813.

Thrivent Financial for Lutherans first reported a position in VIR in Q2 2022 and has held it in 17 quarters since. The position peaked at $1.97M in Q4 2022. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Thrivent Financial for Lutherans held 132,338 shares of Vir Biotechnology worth $1.35M as of Q2 2026.
  • Thrivent Financial for Lutherans bought 18,745 Vir Biotechnology shares in Q2 2026, an estimated $178K.
  • Vir Biotechnology made up ﹤0.01% of Thrivent Financial for Lutherans's portfolio in Q2 2026, its #1813 holding.
  • Thrivent Financial for Lutherans first reported a position in Vir Biotechnology in Q2 2022 and has held it in 17 quarters since.
  • Thrivent Financial for Lutherans's Vir Biotechnology position peaked at $1.97M in Q4 2022.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Thrivent Financial for Lutherans's 13F filing for Q2 2026, filed 14 Aug 2026.